artesunate · Amivas · NDA 213036
Artesunate
Earliest generic entry, as listed
16 Feb 2044
Blocked by patent: US 12121506, US 12390442.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 12121506 | drug product · sets the listed date | 16 Feb 2044 |
| US 12390442 | use U-4433 · sets the listed date | 16 Feb 2044 |
Exclusivities · 1 unexpired
| ODE-290 | orphan drug (7 years) | 26 May 2027 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 213036 · 001 · RLD | powder, intravenous | 110MG/VIAL | 16 Feb 2044 |